ArticleScientific reports2025
Non-adherence to epileptic medications among adult patients in south west Shewa zone hospitals of central Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of depression and epilepsy in rural northern Rwanda: a prospective longitudinal study with a patient-centered approach.Epilepsy & behavior reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy, a global public health problem, affecting about 50 million humans. Non-adherence to antiepileptic medications leads to treatment failure, hospitalization, decreased productivity and death. Previously conducted studies in Ethiopia did not fully identify these factors, which highlights the need for further research. Hence, this study aimed to assess non-adherence to anti-epileptic medications and associated factors among adult patients with epilepsy at the specified study area. Hospital based cross-sectional study was employed to collect data from 361 patients with epilepsy from November 1, 2023 to January 9, 2024. Data was collected using a pretested structured interviewer-administered questionnaire. Systematic random sampling technique was carried out to select study participants. Data was entered into EpiData and exported to Statistical Package for Social Sciences (SPSS) version 25 for analysis. The multivariable logistic regressions were utilized and Adjusted Odds Ratio (AOR), 95% Confidence level and p-value < 0.05 was used to declare statistical significance. In this study, 43.1% (95% CI 37.8, 48.4%) of respondents were non-adherent to anti-epileptic medications. Being on treatment for 1-3 years (AOR = 4.1, 95% CI 1.768, 9.427), unable to get health information about their illness (AOR = 2.36, 95% CI 1.4, 3.9) and distance to the health facility (AOR = 2.7, 95% CI 1.56, 4.66) were factors significantly associated with non-adherence to anti-epileptic medications. The prevalence of non-adherence to anti-epileptic medications was found to be high. Duration on treatment, distance to the health facility and unable to get health information about their illness were predictors of non-adherence. Therefore, it is recommended that providing health education and counseling as well solving distance related problems to the health facility is needed to increase adherence for better treatment outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.